USANA HEALTH SCIENCES, INC. Deferred Tax and Other Liabilities, Noncurrent
USANA HEALTH SCIENCES, INC. (USNA) had Deferred Tax and Other Liabilities, Noncurrent of $4.89 million as of 2026-01-03, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Other Liabilities and Financial Instruments Subject to Mandatory Redemption
us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent · last filed 2026-03-16
- 2026-01-03: Deferred Tax and Other Liabilities, Noncurrent $4.89M.
- 2024-12-28: Deferred Tax and Other Liabilities, Noncurrent $4.07M.
| Period end | Deferred Tax and Other Liabilities, Noncurrent |
|---|---|
| 2026-01-03 | $4.89M 10-K · filed 2026-03-16 |
| 2024-12-28 | $4.07M 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |